chlvpp was easy to administer ( i.e. , 87 % of patients without previous chemotherapy received greater than or equal to 80 % of the planned doses of myelosuppressive drugs ) and was generally well tolerated , with only occasional vomiting from procarbazine and phlebitis from vinblastine .
C0280073
chlvpp
C0042670
vinblastine